|

Gemcitabine/Carboplatin Clinical Trials

1 actively recruiting trial

Also known as: Gemzar/Paraplatin

Pipeline

Phase 1: 1

Top Sponsors

  • Shanghai Jiao Tong University School of Medicine1

Indications

  • Recurrent Non-small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Other1 trial

A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.